Janney Montgomery Scott LLC Axsome Therapeutics, Inc. Transaction History

Janney Montgomery Scott LLC

$32.8 Billion
Q2 2024

A detailed history of Janney Montgomery Scott LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 5,630 shares of AXSM stock, worth $539,579. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,630

Previous 5,780 2.6%

Holding current value

$539,579

Previous $461,000 1.74%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$65.72 - $80.5 $9,858 - $12,075	-150 Reduced 2.6%	5,630 $453,000
Q1 2024 May 01, 2024	BUY	$69.39 - $97.64 $34,695 - $48,820	500 Added 9.47%	5,780 $461,000
Q4 2023 Feb 07, 2024	SELL	$57.42 - $83.61 $16,077 - $23,410	-280 Reduced 5.04%	5,280 $420,000
Q3 2023 Nov 08, 2023	BUY	$69.25 - $82.21 $74,305 - $88,211	1,073 Added 23.91%	5,560 $389,000
Q2 2023 Jul 26, 2023	BUY	$58.41 - $90.35 $262,085 - $405,400	4,487 New	4,487 $322,000
Q4 2022 Feb 01, 2023	BUY	$39.94 - $79.72 $112,031 - $223,614	2,805 New	2,805 $216,000
Q2 2022 Aug 03, 2022	SELL	$21.74 - $46.75 $124,396 - $267,503	-5,722 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$23.7 - $41.39 $7,749 - $13,534	-327 Reduced 5.41%	5,722 $237,000
Q4 2021 Jan 27, 2022	BUY	$30.7 - $43.36 $185,704 - $262,284	6,049 New	6,049 $229,000
Q3 2021 Oct 29, 2021	SELL	$19.91 - $68.26 $209,851 - $719,460	-10,540 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$50.63 - $73.5 $25,315 - $36,750	500 Added 4.98%	10,540 $711,000
Q1 2021 Apr 27, 2021	BUY	$55.91 - $81.44 $4,752 - $6,922	85 Added 0.85%	10,040 $568,000
Q4 2020 Jan 25, 2021	BUY	$66.31 - $86.52 $20,688 - $26,994	312 Added 3.24%	9,955 $811,000
Q3 2020 Nov 06, 2020	SELL	$68.34 - $85.84 $77,155 - $96,913	-1,129 Reduced 10.48%	9,643 $687,000
Q2 2020 Jul 23, 2020	BUY	$49.87 - $98.69 $120,485 - $238,435	2,416 Added 28.91%	10,772 $886,000
Q1 2020 Apr 30, 2020	SELL	$41.2 - $101.31 $576,964 - $1.42 Million	-14,004 Reduced 62.63%	8,356 $492,000
Q4 2019 Jan 21, 2020	SELL	$16.71 - $106.24 $102,181 - $649,657	-6,115 Reduced 21.47%	22,360 $2.31 Million
Q3 2019 Oct 29, 2019	BUY	$20.24 - $29.16 $19,228 - $27,702	950 Added 3.45%	28,475 $576,000
Q2 2019 Jul 29, 2019	BUY	$13.46 - $25.75 $133,927 - $256,212	9,950 Added 56.61%	27,525 $709,000
Q1 2019 Apr 30, 2019	BUY	$2.63 - $16.34 $46,222 - $287,175	17,575 New	17,575 $250,000

Others Institutions Holding AXSM

# of Institutions

288

Shares Held

40.4M

Call Options Held

365K

Put Options Held

428K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.11B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Account

Janney Montgomery Scott LLC Axsome Therapeutics, Inc. Transaction History